Terms: = Brain cancer AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
9 results:
1. Overcoming the Blood-brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for treatment of Temozolomide-Resistant Glioblastoma.
Hsu TI; Chen YP; Zhang RL; Chen ZA; Wu CH; Chang WC; Mou CY; Chan HW; Wu SH
ACS Appl Mater Interfaces; 2024 May; 16(17):21722-21735. PubMed ID: 38629735
[TBL] [Abstract] [Full Text] [Related]
2. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract] [Full Text] [Related]
3. Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial.
Derby S; Jackson MR; Williams K; Stobo J; Kelly C; Sweeting L; Shad S; Herbert C; Short SC; Williamson A; James A; Nowicki S; Bulbeck H; Chalmers AJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1371-1378. PubMed ID: 38211641
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Neural Progenitor Cell-associated Chemoradiotherapy Resistance Gene Set (
Yang Y; Xu X; Xie Y; Liu Y; Ning C; Ai Y; Lv C; Wei H; Ge X; Yi T; Piao Y; Wang X; Jin X
Curr Pharm Des; 2022; 28(26):2189-2202. PubMed ID: 35718975
[TBL] [Abstract] [Full Text] [Related]
5. Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.
Zhong H; Liu S; Cao F; Zhao Y; Zhou J; Tang F; Peng Z; Li Y; Xu S; Wang C; Yang G; Li ZQ
Front Immunol; 2021; 12():709986. PubMed ID: 34512630
[TBL] [Abstract] [Full Text] [Related]
6. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
[TBL] [Abstract] [Full Text] [Related]
7. Sequential Protein-Responsive Nanophotosensitizer Complex for Enhancing Tumor-Specific Therapy.
Li X; Fan H; Guo T; Bai H; Kwon N; Kim KH; Yu S; Cho Y; Kim H; Nam KT; Yoon J; Zhang XB; Tan W
ACS Nano; 2019 Jun; 13(6):6702-6710. PubMed ID: 31184131
[TBL] [Abstract] [Full Text] [Related]
8. Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.
Anderton JA; Lindsey JC; Lusher ME; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
Neuro Oncol; 2008 Dec; 10(6):981-94. PubMed ID: 18664619
[TBL] [Abstract] [Full Text] [Related]
9. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways.
Shankar SL; Mani S; O'Guin KN; Kandimalla ER; Agrawal S; Shafit-Zagardo B
J Neurochem; 2001 Oct; 79(2):426-36. PubMed ID: 11677271
[TBL] [Abstract] [Full Text] [Related]
